Skip to content
10-K

Annual Report

GREEN VISION BIOTECHNOLOGY CORP.

0001640334-21-002258

← back to feed
Filed
Sep 21, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Sep 15, 2021 160.79M sh
Shares Diluted FY 2020 · Dec 31, 2020 160.79M sh
Shares Diluted FY 2020 · Dec 31, 2019 160.79M sh
Operating Cash Flow FY 2020 · Dec 31, 2019 $153.63K
Current Liabilities FY 2020 · Dec 31, 2019 $9.97M
Total Liabilities FY 2020 · Dec 31, 2019 $9.97M
Current Assets FY 2020 · Dec 31, 2019 $98.96K
Total Assets FY 2020 · Dec 31, 2019 $3.06M
Net Income FY 2020 · Dec 31, 2019 −$496.69K
Operating Income FY 2020 · Dec 31, 2019 −$538.49K
Gross Profit FY 2020 · Dec 31, 2019 $12.34K
Cost Of Revenue FY 2020 · Dec 31, 2019 $67.61K
Revenue FY 2020 · Dec 31, 2019 $79.95K
Cash And Equivalents FY 2020 · Dec 31, 2018 $9.11K
Stockholders Equity FY 2020 · Dec 31, 2018 −$6.41M